The short-term clinical effects of super-high flux hemodialysis on refractory complications in maintenance hemodialysis patients

武文汇,卢方平
DOI: https://doi.org/10.3760/cma.j.cn115399-20200827-05001
2020-01-01
Abstract:Objective:To observe the short-term clinical effects of super-high flux hemodialysis on refractory complications in maintenance hemodialysis patients.Methods:A total of 14 maintenance hemodialysis patients with refractory complications, such as intractable uraemia pruritus, neuralgia, refractory hypertension were enrolled.The patients who showed no significant improvement after drug treatment, HD+ HP or HDF were treated with super-high flux dialysis (polysulfone dialyzer LSHT160-A, ultrafiltration coefficient 80, area 1.6 m 2). Clinical outcomes were recorded. Pre-dialysis β 2 microglobulin and plasma albumin were determined at baseline and the end of the treatment. In some patients, dialysate effluents albumin concentration was measured. Results:All the patients showed significant improvement in clinical symptoms. The reduction rate of blood β 2-MG following single dialysis was 54.2%-73.3%, and the loss of albumin in dialysate effluent ranged between 2.2-10.6 g. Compared the albumin before the first with last SHFHD transmission, the plasma albumin was decreased to 4.1%-17.1%. Conclusions:Super-high flux dialysis can remove the intermediate and macromolecular toxins and improve the clinical symptoms of refractory complications in maintenance hemodialysis patients, but increase the loss of albumin.
What problem does this paper attempt to address?